Differences in patient populations, trial duration, dose escalation, baseline weight, diabetes status, adherence, and estimand strategy limit direct comparisons
One of those side effects was a marked increase in all over skin pigmentation, especially on the face, arms, and legs
More research is required
Like liraglutide, it is a GLP-1-only agonist
GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)commonly affect bowel movements, though responses vary widely among patients
The benefits of these medications outweigh the risks for the majority of adults with overweight or obesity, as cancer and cardiovascular disease are the two leading causes of death for adults worldwide [143]